Kexing Biopharm Co., Ltd. (SHA:688136)
China
· Delayed Price · Currency is CNY 25.89
-2.75 (-9.60%)
Apr 29, 2026, 3:00 PM CST
Kexing Biopharm Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Market Capitalization | 5,129 | 6,274 | 4,323 | 4,034 | 4,260 | 5,617 | Upgrade
|
| Market Cap Growth | 5.47% | 45.13% | 7.17% | -5.31% | -24.16% | -30.78% | Upgrade
|
| Enterprise Value | 5,912 | 7,062 | 5,012 | 4,566 | 4,301 | 5,203 | Upgrade
|
| Last Close Price | 25.89 | 31.67 | 21.83 | 20.22 | 21.41 | 28.13 | Upgrade
|
| PE Ratio | 45.65 | 40.33 | 137.32 | - | - | 58.23 | Upgrade
|
| PS Ratio | 3.51 | 4.09 | 3.07 | 3.20 | 3.24 | 4.37 | Upgrade
|
| PB Ratio | 2.97 | 3.58 | 2.64 | 2.47 | 2.36 | 2.94 | Upgrade
|
| P/TBV Ratio | 3.41 | 4.12 | 3.07 | 2.75 | 2.59 | 2.98 | Upgrade
|
| P/FCF Ratio | - | 2611.79 | 340.98 | - | - | - | Upgrade
|
| P/OCF Ratio | 75.98 | 72.93 | 40.53 | - | - | 59.75 | Upgrade
|
| EV/Sales Ratio | 4.05 | 4.60 | 3.56 | 3.63 | 3.27 | 4.05 | Upgrade
|
| EV/EBITDA Ratio | 37.32 | 36.11 | 27.15 | - | - | 67.21 | Upgrade
|
| EV/EBIT Ratio | 103.83 | 72.35 | 50.87 | - | - | 123.25 | Upgrade
|
| EV/FCF Ratio | -281.01 | 2939.59 | 395.29 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.80 | 0.80 | 0.75 | 0.68 | 0.57 | 0.32 | Upgrade
|
| Debt / EBITDA Ratio | 7.12 | 7.12 | 6.18 | - | - | 6.53 | Upgrade
|
| Debt / FCF Ratio | 581.45 | 581.45 | 96.29 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.43 | 0.43 | 0.41 | 0.34 | 0.14 | -0.14 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.82 | 3.82 | 3.61 | -3.26 | -3.60 | -3.57 | Upgrade
|
| Net Debt / FCF Ratio | 310.68 | 310.68 | 52.55 | -1.97 | -0.52 | 0.99 | Upgrade
|
| Asset Turnover | 0.46 | 0.46 | 0.45 | 0.41 | 0.44 | 0.50 | Upgrade
|
| Inventory Turnover | 4.00 | 4.00 | 2.67 | 1.85 | 1.71 | 1.86 | Upgrade
|
| Quick Ratio | 1.37 | 1.37 | 1.28 | 1.37 | 2.18 | 2.09 | Upgrade
|
| Current Ratio | 1.57 | 1.57 | 1.45 | 1.69 | 2.62 | 2.42 | Upgrade
|
| Return on Equity (ROE) | 9.01% | 9.01% | 1.65% | -11.38% | -5.00% | 5.16% | Upgrade
|
| Return on Assets (ROA) | 1.82% | 1.82% | 1.99% | -4.86% | -2.61% | 1.02% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.60% | 3.75% | 2.09% | -11.36% | -6.79% | 3.15% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.90% | 3.90% | 4.30% | -10.20% | -4.80% | 1.90% | Upgrade
|
| Earnings Yield | 2.18% | 2.48% | 0.73% | -4.72% | -2.12% | 1.72% | Upgrade
|
| FCF Yield | -0.41% | 0.04% | 0.29% | -6.90% | -11.39% | -4.95% | Upgrade
|
| Dividend Yield | 0.28% | - | 0.37% | - | - | 0.36% | Upgrade
|
| Payout Ratio | 51.24% | 36.89% | 138.60% | - | - | 29.43% | Upgrade
|
| Buyback Yield / Dilution | -0.08% | -0.08% | 0.74% | 1.21% | -1.93% | -31.59% | Upgrade
|
| Total Shareholder Return | 0.19% | -0.08% | 1.10% | 1.21% | -1.93% | -31.23% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.